JPRN-UMIN000002928已完成2 期
pilot study of intraarterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma patients who do not response to intraarterial 5-fluorouracil/cisplatin combination therapy. - IFN/5FU for advanced HCC patients who do not response to low dose FP
Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical, Hiroshima University0 个研究点目标入组 20 人开始时间: 2009年12月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With other malignant disease. 2) A pregnant woman, or a woman suspected of pregnancy. 3) With severe infectious disease. 4) With history of severe allergy. 5) With severe renal function disease. 6) With severe allergy for 5FU or IFN. 7) With severe bone marrow supression. 8) With pulmonary fibrosis. 9) with shosaikoto 10) with autoimmune hepatitis
研究者
相似试验
已完成
不适用
A trial of intraoperative 5-fluorouracil (5-FU) in primary glaucoma surgery: effects on long term intraocular pressure control and disease progressioGlaucomaEye DiseasesISRCTN81872640Medical Research Council (MRC) (UK)367
已完成
不适用
A randomised trial of infusional 5-fluorouracil and concomitant radiotherapy in locally advanced rectal cancer, comparing three and six months of infusional 5-fluorouracilCancer of rectumCancerISRCTN93845533The Royal Marsden NHS Foundation Trust (UK)
进行中（未招募）
不适用
5-Fluorouracil in relapsed EpendymomaRecurrent or refractory ependymomaMedDRA version: 17.1Level: PTClassification code 10014967Term: EpendymomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001470-34-GBRoyal Marsden NHS Foundation Trust
招募中
3 期
ewer treatment modality for chalazion a benign lid swellingCTRI/2022/06/043117Sadguru Netra Chikitsalya
已完成
1 期
Phase I/II study of arterial infusion of 5-fluorouracil combined with systemic gemcitabine for unresectable pancreatic cancernresectable pancreatic cancerJPRN-UMIN000000573ara Medical University24